Skip to main content

Roche’s Virtual Hematology Investor Event

Roche has hosted a virtual event on 16th June 2024.

Agenda
IntroductionBruno Eschli, Head of Investor Relations
STARGLO: Columvi-GemOx for R/R DLBCL - Results of a Global Randomized Ph III TrialJeremy Abramson, Massachusetts General Hospital Cancer Center, Boston, MA, USA
Roche Bispecific Antibodies in NHLWilliam Waas, Lifecycle Leader NHL Bispecific Program, Global Product Strategy
Hemlibra: Improving Patient ExperienceDaud Chaudry, Lifecycle Leader Hemlibra Program, Global Product Strategy
Q&A

Webinar Replay

InvestorsPast IR Events
View more Events

Downloads

Download Presentation

PDF

Discover more

  • Governance

    About Roche

    Our corporate governance principles focus on sustainable value creation and promote a culture that recognises standards of good corporate governance and a commitment to transparent communication.

  • Product Development Pipeline

    Solutions

    Discover our pipeline of Pharmaceutical and Diagnostics developments

  • Frequently asked questions

    Investors

    We answer the Roche investors-related most frequently asked questions

  • Finance Information Tool

    Investors

    Access the finance information tool for the latest Roche financial data.